Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study

BACKGROUND: Glycemic variability is associated with the development of diabetic complications through the activation of oxidative stress. This study aimed to evaluate the effects of a dipeptidyl peptidase 4 inhibitor, vildagliptin, or a thiazolidinedione, pioglitazone, on glycemic variability and ox...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Nam Hoon, Kim, Dong-Lim, Kim, Kyeong Jin, Kim, Nan Hee, Choi, Kyung Mook, Baik, Sei Hyun, Kim, Sin Gon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503869/
https://www.ncbi.nlm.nih.gov/pubmed/28685513
http://dx.doi.org/10.3803/EnM.2017.32.2.241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503869/
https://www.ncbi.nlm.nih.gov/pubmed/28685513
http://dx.doi.org/10.3803/EnM.2017.32.2.241

Ejemplares similares